Archived News Releases

03/30/26

Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting

03/11/26

Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation

03/06/26

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/04/26

Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare Conference

03/02/26

Pacira BioSciences Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry (IGOR)

02/26/26

Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results

02/12/26

Pacira to Report 2025 Financial Results on Thursday February 26, 2026

02/12/26

Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices

02/09/26

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/28/26

Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors

01/13/26

Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets

01/08/26

Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues

01/07/26

Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences